Cargando…

The risk and added values of the atherosclerotic cardiovascular risk enhancers on prediction of cardiovascular events: Tehran lipid and glucose study

BACKGROUND: In 2013 American College of Cardiology and the American Heart Association released a guideline on the management of atherosclerotic cardiovascular disease (ASCVD) including a composite of death from CVD, non-fatal myocardial infarction, or non-fatal stroke (hard CVD). This guideline reco...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hadaegh, Farzad, Asgari, Samaneh, Moosaie, Fatemeh, Orangi, Meysam, Sarvghadi, Farzaneh, Khalili, Davood, Azizi, Fereidoun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7789723/ https://www.ncbi.nlm.nih.gov/pubmed/33407576 http://dx.doi.org/10.1186/s12967-020-02686-1

Ejemplares similares

External validation of the European risk assessment tool for chronic cardio-metabolic disorders in a Middle Eastern population
por: Asgari, Samaneh, et al.
Publicado: (2020)

12-year trends in cardiovascular risk factors (2002-2005 through 2011-2014) in patients with cardiovascular diseases: Tehran lipid and glucose study
por: Rabani, SeyedHossein, et al.
Publicado: (2018)

Trajectories of cardiovascular disease risk and their association with the incidence of cardiovascular events over 18 years of follow-up: The Tehran Lipid and Glucose study
por: Koohi, Fatemeh, et al.
Publicado: (2021)

Determining the Factors Associated with Cardiovascular Disease Recurrence: Tehran Lipid and Glucose Study
por: Taravatmanesh, Samira, et al.
Publicado: (2017)

Differences in the impact of impaired glucose status on clinical outcomes in younger and older adults: Over a decade of follow-up in the Tehran lipid and glucose study
por: Asgari, Samaneh, et al.
Publicado: (2022)

Incidence and risk factors of severe non‐proliferative/proliferative diabetic retinopathy: More than a decade follow up in the Tehran Lipids and Glucose Study
por: Sardarinia, Mahsa, et al.
Publicado: (2021)

Different Weight Histories and Risk of Incident Coronary Heart Disease and Stroke: Tehran Lipid and Glucose Study
por: Kabootari, Maryam, et al.
Publicado: (2018)

Status of Hypertension in Tehran: Potential impact of the ACC/AHA 2017 and JNC7 Guidelines, 2012–2015
por: Asgari, Samaneh, et al.
Publicado: (2019)

Obesity Paradox and Recurrent Coronary Heart Disease in a Population-Based Study: Tehran Lipid and Glucose Study
por: Asgari, Samaneh, et al.
Publicado: (2016)

Sudden cardiac death among Iranian population: a two decades follow-up of Tehran lipid and glucose study
por: Toreyhi, Hossein, et al.
Publicado: (2021)

Sex-Specific Incidence Rates and Risk Factors for Hypertension During 13 Years of Follow-up: The Tehran Lipid and Glucose Study
por: Asgari, Samaneh, et al.
Publicado: (2020)

Twelve-Year Cardiovascular and Mortality Risk in Relation to Smoking Habits in Type 2 Diabetic and Non-Diabetic Men: Tehran Lipid and Glucose Study
por: Hadaegh, Farzad, et al.
Publicado: (2016)

Correction To: Sex-Specific Incidence Rates and Risk Factors for Hypertension During 13 Years of Follow-up: The Tehran Lipid and Glucose Study
por: Asgari, Samaneh, et al.
Publicado: (2020)

Underestimating the Effect of Lipids on Cardiovascular Events: Regression Dilution Bias in the Population-Based Cohort of Tehran Lipid and Glucose Study
por: Masudi, Sima, et al.
Publicado: (2015)

Change in glucose intolerance status and risk of incident cardiovascular disease: Tehran Lipid and Glucose Study
por: Kabootari, Maryam, et al.
Publicado: (2020)

Serum alkaline phosphatase and the risk of coronary heart disease, stroke and all-cause mortality: Tehran Lipid and Glucose Study
por: Kabootari, Maryam, et al.
Publicado: (2018)

Weight change and risk of cardiovascular disease among adults with type 2 diabetes: more than 14 years of follow-up in the Tehran Lipid and Glucose Study
por: Moazzeni, Seyyed Saeed, et al.
Publicado: (2021)

National trends in cardiovascular health metrics among Iranian adults using results of three cross-sectional STEPwise approaches to surveillance surveys
por: Rahmani, Fatemeh, et al.
Publicado: (2021)

External validation of the American prediction model for incident type 2 diabetes in the Iranian population
por: Asgari, Samaneh, et al.
Publicado: (2023)

Outcomes of a Longitudinal Population-based Cohort Study and Pragmatic Community Trial: Findings from 20 Years of the Tehran Lipid and Glucose Study
por: Khalili, Davood, et al.
Publicado: (2018)

Association of ideal cardiovascular health metrics and incident type 2 diabetes mellitus among an urban population of Iran: One decade follow up in the Tehran Lipid and Glucose Study
por: Asgari, Samaneh, et al.
Publicado: (2022)

Sex specific impact of different obesity phenotypes on the risk of incident hypertension: Tehran lipid and glucose study
por: Kabootari, Maryam, et al.
Publicado: (2019)

The relationship between glucose intolerance status and risk of hospitalization during two decades of follow-up: Tehran lipid and glucose study
por: Rasooli, Rahele, et al.
Publicado: (2022)

Anthropometric indices and the risk of incident sudden cardiac death among adults with and without diabetes: over 15 years of follow-up in The Tehran Lipid and Glucose Study
por: Moazzeni, Seyyed Saeed, et al.
Publicado: (2021)

Sex Specific Incidence Rates of Type 2 Diabetes and Its Risk Factors over 9 Years of Follow-Up: Tehran Lipid and Glucose Study
por: Derakhshan, Arash, et al.
Publicado: (2014)

The Trend of Risk for Cardiovascular Diseases During the Past Decade in Iran, Applying No-Lab and Lab-Based Prediction Models
por: Fahimfar, Noushin, et al.
Publicado: (2023)

Association between Wrist Circumference and Risk of Any Fracture in Adults: Findings from 15 Years of Follow-Up in the Tehran Lipid and Glucose Study
por: Tamehri Zadeh, Seyed Saeed, et al.
Publicado: (2022)

The trend of 10-year cardiovascular risk among diabetic and non-diabetic participants in Tehran Lipid and glucose study: 1999–2018
por: Koohi, Fatemeh, et al.
Publicado: (2022)

Ideal cardiovascular health status and risk of cardiovascular disease and all-cause mortality: over a decade of follow-up in the Tehran lipid and glucose study
por: Hadaegh, Farzad, et al.
Publicado: (2022)

Diabetes Mellitus: Findings from 20 Years of the Tehran Lipid and Glucose Study
por: Ramezankhani, Azra, et al.
Publicado: (2018)

Serum Lipids During 20 Years in the Tehran Lipid and Glucose Study: Prevalence, Trends and Impact on Non-Communicable Diseases
por: Baghbani-Oskouei, Aidin, et al.
Publicado: (2018)

World Bank Income Group, Health Expenditure or Cardiometabolic Risk Factors? A Further Explanation of the Wide Gap in Cardiometabolic Mortality Between Worldwide Countries: An Ecological Study
por: Lotfaliany, Mojtaba, et al.
Publicado: (2018)

Risk Factors for Incidence of Cardiovascular Diseases and All-Cause Mortality in a Middle Eastern Population over a Decade Follow-up: Tehran Lipid and Glucose Study
por: Sardarinia, Mahsa, et al.
Publicado: (2016)

Application of Latent Class Analysis to Identify Metabolic Syndrome Components Patterns in adults: Tehran Lipid and Glucose study
por: Ahanchi, Noushin Sadat, et al.
Publicado: (2019)

The Incidence of Coronary Heart Disease and the Population Attributable Fraction of Its Risk Factors in Tehran: A 10-Year Population-Based Cohort Study
por: Khalili, Davood, et al.
Publicado: (2014)

Trends in Cardiovascular Disease Risk Factors in People with and without Diabetes Mellitus: A Middle Eastern Cohort Study
por: Jahangiri-Noudeh, Younes, et al.
Publicado: (2014)

Impact Of Hypertension versus Diabetes on Cardiovascular and All-cause Mortality in Iranian Older Adults: Results of 14 Years of Follow-up
por: Zafari, Neda, et al.
Publicado: (2017)

A 10-Year Cardiovascular Risk in Adults with Different Levels of Spiritual Health: Tehran Lipid and Glucose Study
por: Amiri, Parisa, et al.
Publicado: (2023)

The association of parity/live birth number with incident type 2 diabetes among women: over 15 years of follow-up in The Tehran Lipid and Glucose Study
por: Moazzeni, Seyyed Saeed, et al.
Publicado: (2021)

The impact of triglyceride-glucose index on incident cardiovascular events during 16 years of follow-up: Tehran Lipid and Glucose Study
por: Barzegar, Niloofar, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_6qfn8bcrunkd0dci7iv95ovgam